FDA: Porton Failed to Follow Contamination Procedures

FDA served Porton Biopharma a warning letter after an inspection revealed failures to notify the agency of changes affecting drugs, and failing to follow procedures to prevent microbiological contamination.
Source: Drug GMP Report